Cargando…
Venom immunotherapy during COVID-19 pandemic: Experience from a University Allergy Center in Northern Italy
During the ongoing pandemic of Coronavirus Disease 2019 (COVID-19) allergic patients need to continue their constant and proper treatment, including allergen-specific immunotherapy. These patients are expected to be at a higher risk for exacerbation of lung inflammation during viral infection. We in...
Autores principales: | Dell’Edera, Alessandro, Borghesan, Franco, Favero, Elisabetta, Rattazzi, Marcello, Scarpa, Riccardo, Tartaglia, Leonardo, Agostini, Carlo, Cinetto, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664475/ https://www.ncbi.nlm.nih.gov/pubmed/33224428 http://dx.doi.org/10.1016/j.waojou.2020.100489 |
Ejemplares similares
-
Comparison between Dexamethasone and Methylprednisolone Therapy in Patients with COVID-19 Pneumonia Admitted to Non-Intensive Medical Units
por: Buso, Roberta, et al.
Publicado: (2021) -
The broad spectrum of lung diseases in primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2018) -
Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study
por: Scarpa, Riccardo, et al.
Publicado: (2022) -
Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
por: Paolocci, Giulia, et al.
Publicado: (2014) -
Stinging insect allergy: current perspectives on venom immunotherapy
por: Ludman, Sian W, et al.
Publicado: (2015)